- Home
- Publications
- Publication Search
- Publication Details
Title
Esketamine: a glimmer of hope in treatment-resistant depression
Authors
Keywords
-
Journal
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-20
DOI
10.1007/s00406-019-01084-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
- (2019) Thu Ha Pham et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
- (2019) Vanina Popova et al. AMERICAN JOURNAL OF PSYCHIATRY
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
- (2019) Maggie Fedgchin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
- (2019) Ella J. Daly et al. JAMA Psychiatry
- Ketamine and depression: a narrative review
- (2019) Alexandrine Corriger et al. Drug Design Development and Therapy
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Common Neurotransmission Recruited in ( R , S )-Ketamine and (2 R ,6 R )-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects
- (2018) Thu Ha Pham et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- S114. Efficacy and Safety of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression
- (2018) Rachel Ochs-Ross et al. BIOLOGICAL PSYCHIATRY
- Is (S)-norketamine an alternative antidepressant for esketamine?
- (2018) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study
- (2018) Randall L. Morrison et al. PSYCHOPHARMACOLOGY
- Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression
- (2018) Ella J. Daly et al. JAMA Psychiatry
- Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
- (2017) Yukihiko Shirayama et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Neuronal plasticity and neurotrophic factors in drug responses
- (2017) E Castrén et al. MOLECULAR PSYCHIATRY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
- (2016) André F. Carvalho et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Risks Associated with Misuse of Ketamine as a Rapid-Acting Antidepressant
- (2016) Weili Zhu et al. Neuroscience Bulletin
- Clonidine for reduction of hemodynamic and psychological effects of S+ ketamine anesthesia for dressing changes in patients with major burns: An RCT
- (2014) Giorgio Pretto et al. BURNS
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)
- (2013) Georges Mion et al. CNS Neuroscience & Therapeutics
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Acute Increases in Plasma Mammalian Target of Rapamycin, Glycogen Synthase Kinase-3β, and Eukaryotic Elongation Factor 2 Phosphorylation After Ketamine Treatment in Three Depressed Patients
- (2012) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors
- (2012) Ruin Moaddel et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression
- (2012) Sarah M. Szymkowicz et al. JOURNAL OF AFFECTIVE DISORDERS
- Monitoring Ketamine Treatment Response in a Depressed Patient via Peripheral Mammalian Target of Rapamycin Activation
- (2011) Magdalena C. Denk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effect of Rifampicin on S-ketamine and S-norketamine Plasma Concentrations in Healthy Volunteers after Intravenous S-ketamine Administration
- (2011) Ingeborg Noppers et al. ANESTHESIOLOGY
- Exposure to Oral S-ketamine Is Unaffected by Itraconazole but Greatly Increased by Ticlopidine
- (2011) M A Peltoniemi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- St John’s wort greatly decreases the plasma concentrations of oral S-ketamine
- (2011) Marko A. Peltoniemi et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Clarithromycin, a potent inhibitor of CYP3A, greatly increases exposure to oral S-ketamine
- (2009) Nora M. Hagelberg et al. EUROPEAN JOURNAL OF PAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search